 | • レポートコード：B-GIR09F3187 • 出版社/出版日：GlobalInfoResearch / 2019年9月13日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、123ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、レボセチリジン薬の世界市場について調べ、まとめました。種類別セグメントは、タブレット、経口液等、用途別セグメントは、65歳以上、12-64歳、6-11歳、2-5歳等に区分しました。レボセチリジン薬の世界市場概観、企業動向、企業別レボセチリジン薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・レボセチリジン薬の市場概観 ・レボセチリジン薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・レボセチリジン薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・レボセチリジン薬の世界市場規模 ・レボセチリジン薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・レボセチリジン薬のアメリカ市場規模推移 ・レボセチリジン薬のカナダ市場規模推移 ・レボセチリジン薬のメキシコ市場規模推移 ・レボセチリジン薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・レボセチリジン薬のドイツ市場規模推移 ・レボセチリジン薬のイギリス市場規模推移 ・レボセチリジン薬のロシア市場規模推移 ・レボセチリジン薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・レボセチリジン薬の日本市場規模推移 ・レボセチリジン薬の中国市場規模推移 ・レボセチリジン薬の韓国市場規模推移 ・レボセチリジン薬のインド市場規模推移 ・レボセチリジン薬の東南アジア市場規模推移 ・レボセチリジン薬の南米市場分析（ブラジル、アルゼンチン等） ・レボセチリジン薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・レボセチリジン薬の種類別分析/販売量、売上、市場シェア（タブレット、経口液） ・レボセチリジン薬の用途別分析/市場規模（65歳以上、12-64歳、6-11歳、2-5歳） ・レボセチリジン薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・レボセチリジン薬の販売チャネル・代理店・貿易業者・ディーラー分析 |
Levocetirizine is an antihistamine used to relieve allergy symptoms such as watery eyes, runny nose, itching eyes/nose, and sneezing. It is also used to relieve itching and hives. It works by blocking a certain natural substance (histamine) that your body makes during an allergic reaction.
Scope of the Report:
The global Levocetirizine Drug market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Levocetirizine Drug.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Levocetirizine Drug market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Levocetirizine Drug market by product type and applications/end industries.
Market Segment by Companies, this report covers
Sanofi
Teva
Sun Pharma
Synthon
Perrigo
Glenmark Pharmaceutical
Dr.Reddy’s
Hetero
Micro Labs
Taro Pharmaceutical
Apotex
Lannett
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Tablets
Oral Solution
Market Segment by Applications, can be divided into
65 years of age and older
12-64 years of age
6-11 years of age
2-5 years of age
Table of Contents
1 Levocetirizine Drug Market Overview
1.1 Product Overview and Scope of Levocetirizine Drug
1.2 Classification of Levocetirizine Drug by Types
1.2.1 Global Levocetirizine Drug Revenue Comparison by Types (2019-2024)
1.2.2 Global Levocetirizine Drug Revenue Market Share by Types in 2018
1.2.3 Tablets
1.2.4 Oral Solution
1.3 Global Levocetirizine Drug Market by Application
1.3.1 Global Levocetirizine Drug Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 65 years of age and older
1.3.3 12-64 years of age
1.3.4 6-11 years of age
1.3.5 2-5 years of age
1.4 Global Levocetirizine Drug Market by Regions
1.4.1 Global Levocetirizine Drug Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Levocetirizine Drug Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Levocetirizine Drug Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Levocetirizine Drug Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Levocetirizine Drug Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Levocetirizine Drug Status and Prospect (2014-2024)
1.5 Global Market Size of Levocetirizine Drug (2014-2024)
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Business Overview
2.1.2 Levocetirizine Drug Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Sanofi Levocetirizine Drug Revenue, Gross Margin and Market Share (2017-2018)
2.2 Teva
2.2.1 Business Overview
2.2.2 Levocetirizine Drug Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Teva Levocetirizine Drug Revenue, Gross Margin and Market Share (2017-2018)
2.3 Sun Pharma
2.3.1 Business Overview
2.3.2 Levocetirizine Drug Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Sun Pharma Levocetirizine Drug Revenue, Gross Margin and Market Share (2017-2018)
2.4 Synthon
2.4.1 Business Overview
2.4.2 Levocetirizine Drug Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Synthon Levocetirizine Drug Revenue, Gross Margin and Market Share (2017-2018)
2.5 Perrigo
2.5.1 Business Overview
2.5.2 Levocetirizine Drug Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Perrigo Levocetirizine Drug Revenue, Gross Margin and Market Share (2017-2018)
2.6 Glenmark Pharmaceutical
2.6.1 Business Overview
2.6.2 Levocetirizine Drug Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Glenmark Pharmaceutical Levocetirizine Drug Revenue, Gross Margin and Market Share (2017-2018)
2.7 Dr.Reddy’s
2.7.1 Business Overview
2.7.2 Levocetirizine Drug Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Dr.Reddy’s Levocetirizine Drug Revenue, Gross Margin and Market Share (2017-2018)
2.8 Hetero
2.8.1 Business Overview
2.8.2 Levocetirizine Drug Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Hetero Levocetirizine Drug Revenue, Gross Margin and Market Share (2017-2018)
2.9 Micro Labs
2.9.1 Business Overview
2.9.2 Levocetirizine Drug Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Micro Labs Levocetirizine Drug Revenue, Gross Margin and Market Share (2017-2018)
2.10 Taro Pharmaceutical
2.10.1 Business Overview
2.10.2 Levocetirizine Drug Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Taro Pharmaceutical Levocetirizine Drug Revenue, Gross Margin and Market Share (2017-2018)
2.11 Apotex
2.11.1 Business Overview
2.11.2 Levocetirizine Drug Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Apotex Levocetirizine Drug Revenue, Gross Margin and Market Share (2017-2018)
2.12 Lannett
2.12.1 Business Overview
2.12.2 Levocetirizine Drug Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Lannett Levocetirizine Drug Revenue, Gross Margin and Market Share (2017-2018)
3 Global Levocetirizine Drug Market Competition, by Players
3.1 Global Levocetirizine Drug Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Levocetirizine Drug Players Market Share
3.2.2 Top 10 Levocetirizine Drug Players Market Share
3.3 Market Competition Trend
4 Global Levocetirizine Drug Market Size by Regions
4.1 Global Levocetirizine Drug Revenue and Market Share by Regions
4.2 North America Levocetirizine Drug Revenue and Growth Rate (2014-2019)
4.3 Europe Levocetirizine Drug Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Levocetirizine Drug Revenue and Growth Rate (2014-2019)
4.5 South America Levocetirizine Drug Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Levocetirizine Drug Revenue and Growth Rate (2014-2019)
5 North America Levocetirizine Drug Revenue by Countries
5.1 North America Levocetirizine Drug Revenue by Countries (2014-2019)
5.2 USA Levocetirizine Drug Revenue and Growth Rate (2014-2019)
5.3 Canada Levocetirizine Drug Revenue and Growth Rate (2014-2019)
5.4 Mexico Levocetirizine Drug Revenue and Growth Rate (2014-2019)
6 Europe Levocetirizine Drug Revenue by Countries
6.1 Europe Levocetirizine Drug Revenue by Countries (2014-2019)
6.2 Germany Levocetirizine Drug Revenue and Growth Rate (2014-2019)
6.3 UK Levocetirizine Drug Revenue and Growth Rate (2014-2019)
6.4 France Levocetirizine Drug Revenue and Growth Rate (2014-2019)
6.5 Russia Levocetirizine Drug Revenue and Growth Rate (2014-2019)
6.6 Italy Levocetirizine Drug Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Levocetirizine Drug Revenue by Countries
7.1 Asia-Pacific Levocetirizine Drug Revenue by Countries (2014-2019)
7.2 China Levocetirizine Drug Revenue and Growth Rate (2014-2019)
7.3 Japan Levocetirizine Drug Revenue and Growth Rate (2014-2019)
7.4 Korea Levocetirizine Drug Revenue and Growth Rate (2014-2019)
7.5 India Levocetirizine Drug Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Levocetirizine Drug Revenue and Growth Rate (2014-2019)
8 South America Levocetirizine Drug Revenue by Countries
8.1 South America Levocetirizine Drug Revenue by Countries (2014-2019)
8.2 Brazil Levocetirizine Drug Revenue and Growth Rate (2014-2019)
8.3 Argentina Levocetirizine Drug Revenue and Growth Rate (2014-2019)
8.4 Colombia Levocetirizine Drug Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Levocetirizine Drug by Countries
9.1 Middle East and Africa Levocetirizine Drug Revenue by Countries (2014-2019)
9.2 Saudi Arabia Levocetirizine Drug Revenue and Growth Rate (2014-2019)
9.3 UAE Levocetirizine Drug Revenue and Growth Rate (2014-2019)
9.4 Egypt Levocetirizine Drug Revenue and Growth Rate (2014-2019)
9.5 Nigeria Levocetirizine Drug Revenue and Growth Rate (2014-2019)
9.6 South Africa Levocetirizine Drug Revenue and Growth Rate (2014-2019)
10 Global Levocetirizine Drug Market Segment by Type
10.1 Global Levocetirizine Drug Revenue and Market Share by Type (2014-2019)
10.2 Global Levocetirizine Drug Market Forecast by Type (2019-2024)
10.3 Tablets Revenue Growth Rate (2014-2024)
10.4 Oral Solution Revenue Growth Rate (2014-2024)
11 Global Levocetirizine Drug Market Segment by Application
11.1 Global Levocetirizine Drug Revenue Market Share by Application (2014-2019)
11.2 Levocetirizine Drug Market Forecast by Application (2019-2024)
11.3 65 years of age and older Revenue Growth (2014-2019)
11.4 12-64 years of age Revenue Growth (2014-2019)
11.5 6-11 years of age Revenue Growth (2014-2019)
11.6 2-5 years of age Revenue Growth (2014-2019)
12 Global Levocetirizine Drug Market Size Forecast (2019-2024)
12.1 Global Levocetirizine Drug Market Size Forecast (2019-2024)
12.2 Global Levocetirizine Drug Market Forecast by Regions (2019-2024)
12.3 North America Levocetirizine Drug Revenue Market Forecast (2019-2024)
12.4 Europe Levocetirizine Drug Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Levocetirizine Drug Revenue Market Forecast (2019-2024)
12.6 South America Levocetirizine Drug Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Levocetirizine Drug Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Levocetirizine Drug Picture
Table Product Specifications of Levocetirizine Drug
Table Global Levocetirizine Drug and Revenue (Million USD) Market Split by Product Type
Figure Global Levocetirizine Drug Revenue Market Share by Types in 2018
Figure Tablets Picture
Figure Oral Solution Picture
Table Global Levocetirizine Drug Revenue (Million USD) by Application (2014-2024)
Figure Levocetirizine Drug Revenue Market Share by Applications in 2018
Figure 65 years of age and older Picture
Figure 12-64 years of age Picture
Figure 6-11 years of age Picture
Figure 2-5 years of age Picture
Table Global Market Levocetirizine Drug Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Levocetirizine Drug Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Levocetirizine Drug Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Levocetirizine Drug Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Levocetirizine Drug Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Levocetirizine Drug Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Levocetirizine Drug Revenue (Million USD) and Growth Rate (2014-2024)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Levocetirizine Drug Type and Applications
Table Sanofi Levocetirizine Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Levocetirizine Drug Type and Applications
Table Teva Levocetirizine Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Sun Pharma Basic Information, Manufacturing Base and Competitors
Table Sun Pharma Levocetirizine Drug Type and Applications
Table Sun Pharma Levocetirizine Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Synthon Basic Information, Manufacturing Base and Competitors
Table Synthon Levocetirizine Drug Type and Applications
Table Synthon Levocetirizine Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Perrigo Basic Information, Manufacturing Base and Competitors
Table Perrigo Levocetirizine Drug Type and Applications
Table Perrigo Levocetirizine Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Glenmark Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Glenmark Pharmaceutical Levocetirizine Drug Type and Applications
Table Glenmark Pharmaceutical Levocetirizine Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Dr.Reddy's Basic Information, Manufacturing Base and Competitors
Table Dr.Reddy's Levocetirizine Drug Type and Applications
Table Dr.Reddy's Levocetirizine Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Hetero Basic Information, Manufacturing Base and Competitors
Table Hetero Levocetirizine Drug Type and Applications
Table Hetero Levocetirizine Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Micro Labs Basic Information, Manufacturing Base and Competitors
Table Micro Labs Levocetirizine Drug Type and Applications
Table Micro Labs Levocetirizine Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Taro Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Taro Pharmaceutical Levocetirizine Drug Type and Applications
Table Taro Pharmaceutical Levocetirizine Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Apotex Basic Information, Manufacturing Base and Competitors
Table Apotex Levocetirizine Drug Type and Applications
Table Apotex Levocetirizine Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Lannett Basic Information, Manufacturing Base and Competitors
Table Lannett Levocetirizine Drug Type and Applications
Table Lannett Levocetirizine Drug Revenue, Gross Margin and Market Share (2017-2018)
Table Global Levocetirizine Drug Revenue (Million USD) by Players (2014-2019)
Table Global Levocetirizine Drug Revenue Share by Players (2014-2019)
Figure Global Levocetirizine Drug Revenue Share by Players in 2017
Figure Global Levocetirizine Drug Revenue Share by Players in 2018
Figure Global Top 5 Players Levocetirizine Drug Revenue Market Share in 2018
Figure Global Top 10 Players Levocetirizine Drug Revenue Market Share in 2018
Figure Global Levocetirizine Drug Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Levocetirizine Drug Revenue (Million USD) by Regions (2014-2019)
Table Global Levocetirizine Drug Revenue Market Share by Regions (2014-2019)
Figure Global Levocetirizine Drug Revenue Market Share by Regions (2014-2019)
Figure Global Levocetirizine Drug Revenue Market Share by Regions in 2018
Figure North America Levocetirizine Drug Revenue and Growth Rate (2014-2019)
Figure Europe Levocetirizine Drug Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Levocetirizine Drug Revenue and Growth Rate (2014-2019)
Figure South America Levocetirizine Drug Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Levocetirizine Drug Revenue and Growth Rate (2014-2019)
Table North America Levocetirizine Drug Revenue by Countries (2014-2019)
Table North America Levocetirizine Drug Revenue Market Share by Countries (2014-2019)
Figure North America Levocetirizine Drug Revenue Market Share by Countries (2014-2019)
Figure North America Levocetirizine Drug Revenue Market Share by Countries in 2018
Figure USA Levocetirizine Drug Revenue and Growth Rate (2014-2019)
Figure Canada Levocetirizine Drug Revenue and Growth Rate (2014-2019)
Figure Mexico Levocetirizine Drug Revenue and Growth Rate (2014-2019)
Table Europe Levocetirizine Drug Revenue (Million USD) by Countries (2014-2019)
Figure Europe Levocetirizine Drug Revenue Market Share by Countries (2014-2019)
Figure Europe Levocetirizine Drug Revenue Market Share by Countries in 2018
Figure Germany Levocetirizine Drug Revenue and Growth Rate (2014-2019)
Figure UK Levocetirizine Drug Revenue and Growth Rate (2014-2019)
Figure France Levocetirizine Drug Revenue and Growth Rate (2014-2019)
Figure Russia Levocetirizine Drug Revenue and Growth Rate (2014-2019)
Figure Italy Levocetirizine Drug Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Levocetirizine Drug Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Levocetirizine Drug Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Levocetirizine Drug Revenue Market Share by Countries in 2018
Figure China Levocetirizine Drug Revenue and Growth Rate (2014-2019)
Figure Japan Levocetirizine Drug Revenue and Growth Rate (2014-2019)
Figure Korea Levocetirizine Drug Revenue and Growth Rate (2014-2019)
Figure India Levocetirizine Drug Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Levocetirizine Drug Revenue and Growth Rate (2014-2019)
Table South America Levocetirizine Drug Revenue by Countries (2014-2019)
Table South America Levocetirizine Drug Revenue Market Share by Countries (2014-2019)
Figure South America Levocetirizine Drug Revenue Market Share by Countries (2014-2019)
Figure South America Levocetirizine Drug Revenue Market Share by Countries in 2018
Figure Brazil Levocetirizine Drug Revenue and Growth Rate (2014-2019)
Figure Argentina Levocetirizine Drug Revenue and Growth Rate (2014-2019)
Figure Colombia Levocetirizine Drug Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Levocetirizine Drug Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Levocetirizine Drug Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Levocetirizine Drug Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Levocetirizine Drug Revenue Market Share by Countries in 2018
Figure Saudi Arabia Levocetirizine Drug Revenue and Growth Rate (2014-2019)
Figure UAE Levocetirizine Drug Revenue and Growth Rate (2014-2019)
Figure Egypt Levocetirizine Drug Revenue and Growth Rate (2014-2019)
Figure Nigeria Levocetirizine Drug Revenue and Growth Rate (2014-2019)
Figure South Africa Levocetirizine Drug Revenue and Growth Rate (2014-2019)
Table Global Levocetirizine Drug Revenue (Million USD) by Type (2014-2019)
Table Global Levocetirizine Drug Revenue Share by Type (2014-2019)
Figure Global Levocetirizine Drug Revenue Share by Type (2014-2019)
Figure Global Levocetirizine Drug Revenue Share by Type in 2019
Table Global Levocetirizine Drug Revenue Forecast by Type (2019-2024)
Figure Global Levocetirizine Drug Market Share Forecast by Type (2019-2024)
Figure Global Tablets Revenue Growth Rate (2014-2019)
Figure Global Oral Solution Revenue Growth Rate (2014-2019)
Table Global Levocetirizine Drug Revenue by Application (2014-2019)
Table Global Levocetirizine Drug Revenue Share by Application (2014-2019)
Figure Global Levocetirizine Drug Revenue Share by Application (2014-2019)
Figure Global Levocetirizine Drug Revenue Share by Application in 2019
Table Global Levocetirizine Drug Revenue Forecast by Application (2019-2024)
Figure Global Levocetirizine Drug Market Share Forecast by Application (2019-2024)
Figure Global 65 years of age and older Revenue Growth Rate (2014-2019)
Figure Global 12-64 years of age Revenue Growth Rate (2014-2019)
Figure Global 6-11 years of age Revenue Growth Rate (2014-2019)
Figure Global 2-5 years of age Revenue Growth Rate (2014-2019)
Figure Global Levocetirizine Drug Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Levocetirizine Drug Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Levocetirizine Drug Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Levocetirizine Drug Revenue Market Forecast (2019-2024)
Figure Europe Levocetirizine Drug Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Levocetirizine Drug Revenue Market Forecast (2019-2024)
Figure South America Levocetirizine Drug Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Levocetirizine Drug Revenue Market Forecast (2019-2024)
世界のスニチニブ薬市場予測（～2024年）：企業別、地域別、種類・用途別 Sunitinib (marketed as Sutent by Pfizer, and previously known as SU11248) is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on J…- 世界のアンブリセンタン薬市場予測（～2024年）：企業別、地域別、種類・用途別 Ambrisentan (U.S. trade name Letairis; E.U. trade name Volibris; India trade name Pulmonext by MSN labs) is a drug indicated for use in the treatment of pulmonary hypertension. Scope of the Report: The global Ambrisentan Drug market is valued at xx million USD in 2018 and is expected to reach xx mil…
- 世界のデシタビン薬市場予測（～2024年）：企業別、地域別、種類・用途別 Decitabine (trade name Dacogen), or 5-aza-2'-deoxycytidine, acts as an Nucleic Acid Synthesis Inhibitor. It is a drug for the treatment of myelodysplastic syndromes, a class of conditions where certain blood cells are dysfunctional, and for acute myeloid leukemia (AML). Scope of the Report: The glob…
- 世界のシクロベンザプリン薬市場予測（～2024年）：企業別、地域別、種類・用途別 Cyclobenzaprine is used with rest, physical therapy, and other measures to relax muscles and relieve pain and discomfort caused by strains, sprains, and other muscle injuries. Cyclobenzaprine is in a class of medications called skeletal muscle relaxants. It works by acting in the brain and nervous s…
- 世界の医薬品在庫管理ソフトウェア市場予測（～2024年）：企業別、地域別、種類・用途別 Scope of the Report: The global Drug Inventory Management Software market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially …